
    
      In the study will be included patients with alcoholic and non-alcoholic steatohepatitis
      evaluated in Research Center of Gastroenterology and Hepatology and Gastroenterology Clinic
      of University of Medicine and Pharmacy of Craiova. All the patients will undergo MRI and MRI
      Spectroscopy (3 Tesla) using PHILIPS INGENIA 3T System for exact steatosis quantification.
      The eligible patients will be treated with combination Silimarin, Phyllanthus Niruri and
      Choline (Stoptoxin Forte) for 6 months (in conformity Product Characteristics). After the
      treatment a new IRM Spectroscopy examination will be performed. All the acquired data will be
      analyzed and published.
    
  